Enfusion, Inc.
NYSE:ENFN
8.05 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 174.535 | 150.349 | 111.7 | 79.565 | 59.027 |
| Cost of Revenue
| 57.641 | 47.1 | 31.845 | 21.358 | 16.961 |
| Gross Profit
| 116.894 | 103.249 | 79.855 | 58.207 | 42.066 |
| Gross Profit Ratio
| 0.67 | 0.687 | 0.715 | 0.732 | 0.713 |
| Reseach & Development Expenses
| 19.893 | 17.163 | 153.4 | 6.318 | 4.146 |
| General & Administrative Expenses
| 64.635 | 68.764 | 150.614 | 35.888 | 16.625 |
| Selling & Marketing Expenses
| 20.418 | 29.286 | 51.725 | 9.927 | 7.426 |
| SG&A
| 85.053 | 98.05 | 202.339 | 45.815 | 24.051 |
| Other Expenses
| -2.105 | -0.638 | -1.185 | 0.082 | -0.003 |
| Operating Expenses
| 104.946 | 115.213 | 355.739 | 52.133 | 28.197 |
| Operating Income
| 11.948 | -11.964 | -275.884 | 6.074 | 13.869 |
| Operating Income Ratio
| 0.068 | -0.08 | -2.47 | 0.076 | 0.235 |
| Total Other Income Expenses Net
| -0.464 | -0.225 | -5.779 | -1.58 | -0.727 |
| Income Before Tax
| 11.484 | -12.189 | -281.663 | 4.494 | 13.142 |
| Income Before Tax Ratio
| 0.066 | -0.081 | -2.522 | 0.056 | 0.223 |
| Income Tax Expense
| 2.231 | 1.074 | 0.579 | 0.433 | 0.486 |
| Net Income
| 6.025 | -13.263 | -282.242 | 4.061 | 12.656 |
| Net Income Ratio
| 0.035 | -0.088 | -2.527 | 0.051 | 0.214 |
| EPS
| 0.068 | -0.16 | -4.3 | 0.036 | 0.11 |
| EPS Diluted
| 0.047 | -0.16 | -4.3 | 0.036 | 0.11 |
| EBITDA
| 20.535 | -5.62 | -273.094 | 8.447 | 15.023 |
| EBITDA Ratio
| 0.118 | -0.037 | -2.445 | 0.106 | 0.255 |